Tardive Oculogyric Crisis due to Aripiprazole treatment in an adolescent patient diagnosed with Bipolar Disorder
| Autor: | Şermin Yalın Sapmaz, Aylin Deniz Uzun, Tuğçe Canol, Hasan Kandemir |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Pediatrics
medicine.medical_specialty medicine.drug_class Oculogyric crisis business.industry Atypical antipsychotic medicine.disease Adolescent patient Typical antipsychotic Psychiatry and Mental health Tolerability medicine Quetiapine Pharmacology (medical) Aripiprazole Bipolar disorder business medicine.drug |
| Zdroj: | Psychiatry and Clinical Psychopharmacology. 30:1 |
| ISSN: | 2475-0581 |
| DOI: | 10.5455/pcp.20200522115147 |
| Popis: | Antipsychotics usage in children and adolescents is becoming widespread. One of the extrapyramidal side effects associated with long-term antipsychotic drug use follow-up is an oculogyric crisis (OGC). OGC is defined as a dystonic reaction commonly observed after typical antipsychotic drug administration. However, there are rare cases which report OGC after atypical antipsychotic use. In this report, we present an adolescent with bipolar disorder who developed OGC after 2 years of aripiprazole and quetiapine use. To best of our knowledge, this case report has been the first case to present the clinical presentation of tardive OGC due to aripiprazole treatment in an adolescent patient. It is important to note that OGC might be observed in the acute phase and it might be as a result of chronic use detected during a clinical follow-up. Safety, tolerability and efficiency of aripiprazole in pediatric populations should be further analyzed in the future studies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|